- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
According to our latest study, the global Induced Pluripotent Stem Cells (iPSCs) market size was valued at USD 104.4 million in 2022 and is forecast to a readjusted size of USD 227.6 million by 2029 with a CAGR of 11.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.
This report is a detailed and comprehensive analysis for global Induced Pluripotent Stem Cells (iPSCs) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Induced Pluripotent Stem Cells (iPSCs) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Induced Pluripotent Stem Cells (iPSCs) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Induced Pluripotent Stem Cells (iPSCs) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Induced Pluripotent Stem Cells (iPSCs) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Induced Pluripotent Stem Cells (iPSCs)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Induced Pluripotent Stem Cells (iPSCs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc and Fate Therapeutics, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Human iPSCs
Mouse iPSCs
Market segment by Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Market segment by players, this report covers
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Induced Pluripotent Stem Cells (iPSCs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Induced Pluripotent Stem Cells (iPSCs), with revenue, gross margin and global market share of Induced Pluripotent Stem Cells (iPSCs) from 2018 to 2023.
Chapter 3, the Induced Pluripotent Stem Cells (iPSCs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Induced Pluripotent Stem Cells (iPSCs) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Induced Pluripotent Stem Cells (iPSCs).
Chapter 13, to describe Induced Pluripotent Stem Cells (iPSCs) research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells (iPSCs)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Induced Pluripotent Stem Cells (iPSCs) by Type
1.3.1 Overview: Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type in 2022
1.3.3 Human iPSCs
1.3.4 Mouse iPSCs
1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market by Application
1.4.1 Overview: Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Academic Research
1.4.3 Drug Development and Discovery
1.4.4 Toxicity Screening
1.4.5 Regenerative Medicine
1.4.6 Others
1.5 Global Induced Pluripotent Stem Cells (iPSCs) Market Size & Forecast
1.6 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Region
1.6.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region, (2018-2029)
1.6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2018-2029)
1.6.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2018-2029)
1.6.6 South America Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Fujifilm Holding Corporation (CDI)
2.1.1 Fujifilm Holding Corporation (CDI) Details
2.1.2 Fujifilm Holding Corporation (CDI) Major Business
2.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Fujifilm Holding Corporation (CDI) Recent Developments and Future Plans
2.2 Ncardia
2.2.1 Ncardia Details
2.2.2 Ncardia Major Business
2.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ncardia Recent Developments and Future Plans
2.3 Sumitomo Dainippon Pharma
2.3.1 Sumitomo Dainippon Pharma Details
2.3.2 Sumitomo Dainippon Pharma Major Business
2.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sumitomo Dainippon Pharma Recent Developments and Future Plans
2.4 Astellas Pharma Inc
2.4.1 Astellas Pharma Inc Details
2.4.2 Astellas Pharma Inc Major Business
2.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Astellas Pharma Inc Recent Developments and Future Plans
2.5 Fate Therapeutics, Inc
2.5.1 Fate Therapeutics, Inc Details
2.5.2 Fate Therapeutics, Inc Major Business
2.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fate Therapeutics, Inc Recent Developments and Future Plans
2.6 Pluricell Biotech
2.6.1 Pluricell Biotech Details
2.6.2 Pluricell Biotech Major Business
2.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pluricell Biotech Recent Developments and Future Plans
2.7 Cell Inspire Biotechnology
2.7.1 Cell Inspire Biotechnology Details
2.7.2 Cell Inspire Biotechnology Major Business
2.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cell Inspire Biotechnology Recent Developments and Future Plans
2.8 ReproCELL
2.8.1 ReproCELL Details
2.8.2 ReproCELL Major Business
2.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
2.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ReproCELL Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Induced Pluripotent Stem Cells (iPSCs) by Company Revenue
3.2.2 Top 3 Induced Pluripotent Stem Cells (iPSCs) Players Market Share in 2022
3.2.3 Top 6 Induced Pluripotent Stem Cells (iPSCs) Players Market Share in 2022
3.3 Induced Pluripotent Stem Cells (iPSCs) Market: Overall Company Footprint Analysis
3.3.1 Induced Pluripotent Stem Cells (iPSCs) Market: Region Footprint
3.3.2 Induced Pluripotent Stem Cells (iPSCs) Market: Company Product Type Footprint
3.3.3 Induced Pluripotent Stem Cells (iPSCs) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2018-2023)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2024-2029)
6 North America
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2029)
6.2 North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2029)
6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
6.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2029)
6.3.2 United States Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
6.3.3 Canada Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
6.3.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2029)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2029)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
7.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2029)
7.3.2 Germany Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
7.3.3 France Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
7.3.5 Russia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
7.3.6 Italy Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region
8.3.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Region (2018-2029)
8.3.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
8.3.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
8.3.4 South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
8.3.5 India Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
8.3.7 Australia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
9 South America
9.1 South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2029)
9.2 South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2029)
9.3 South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
9.3.1 South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2029)
9.3.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
9.3.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
10.3.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2029)
10.3.2 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
10.3.4 UAE Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Induced Pluripotent Stem Cells (iPSCs) Market Drivers
11.2 Induced Pluripotent Stem Cells (iPSCs) Market Restraints
11.3 Induced Pluripotent Stem Cells (iPSCs) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Induced Pluripotent Stem Cells (iPSCs) Industry Chain
12.2 Induced Pluripotent Stem Cells (iPSCs) Upstream Analysis
12.3 Induced Pluripotent Stem Cells (iPSCs) Midstream Analysis
12.4 Induced Pluripotent Stem Cells (iPSCs) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Fujifilm Holding Corporation (CDI) Company Information, Head Office, and Major Competitors
Table 6. Fujifilm Holding Corporation (CDI) Major Business
Table 7. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 8. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Fujifilm Holding Corporation (CDI) Recent Developments and Future Plans
Table 10. Ncardia Company Information, Head Office, and Major Competitors
Table 11. Ncardia Major Business
Table 12. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 13. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Ncardia Recent Developments and Future Plans
Table 15. Sumitomo Dainippon Pharma Company Information, Head Office, and Major Competitors
Table 16. Sumitomo Dainippon Pharma Major Business
Table 17. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 18. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Sumitomo Dainippon Pharma Recent Developments and Future Plans
Table 20. Astellas Pharma Inc Company Information, Head Office, and Major Competitors
Table 21. Astellas Pharma Inc Major Business
Table 22. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 23. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Astellas Pharma Inc Recent Developments and Future Plans
Table 25. Fate Therapeutics, Inc Company Information, Head Office, and Major Competitors
Table 26. Fate Therapeutics, Inc Major Business
Table 27. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 28. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Fate Therapeutics, Inc Recent Developments and Future Plans
Table 30. Pluricell Biotech Company Information, Head Office, and Major Competitors
Table 31. Pluricell Biotech Major Business
Table 32. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 33. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pluricell Biotech Recent Developments and Future Plans
Table 35. Cell Inspire Biotechnology Company Information, Head Office, and Major Competitors
Table 36. Cell Inspire Biotechnology Major Business
Table 37. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 38. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Cell Inspire Biotechnology Recent Developments and Future Plans
Table 40. ReproCELL Company Information, Head Office, and Major Competitors
Table 41. ReproCELL Major Business
Table 42. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product and Solutions
Table 43. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. ReproCELL Recent Developments and Future Plans
Table 45. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Players (2018-2023)
Table 46. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players (2018-2023)
Table 47. Breakdown of Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Induced Pluripotent Stem Cells (iPSCs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Induced Pluripotent Stem Cells (iPSCs) Players
Table 50. Induced Pluripotent Stem Cells (iPSCs) Market: Company Product Type Footprint
Table 51. Induced Pluripotent Stem Cells (iPSCs) Market: Company Product Application Footprint
Table 52. Induced Pluripotent Stem Cells (iPSCs) New Market Entrants and Barriers to Market Entry
Table 53. Induced Pluripotent Stem Cells (iPSCs) Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Share by Type (2018-2023)
Table 56. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Forecast by Type (2024-2029)
Table 57. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2023)
Table 58. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Forecast by Application (2024-2029)
Table 59. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Induced Pluripotent Stem Cells (iPSCs) Raw Material
Table 90. Key Suppliers of Induced Pluripotent Stem Cells (iPSCs) Raw Materials
List of Figures
Figure 1. Induced Pluripotent Stem Cells (iPSCs) Picture
Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type in 2022
Figure 4. Human iPSCs
Figure 5. Mouse iPSCs
Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application in 2022
Figure 8. Academic Research Picture
Figure 9. Drug Development and Discovery Picture
Figure 10. Toxicity Screening Picture
Figure 11. Regenerative Medicine Picture
Figure 12. Others Picture
Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Induced Pluripotent Stem Cells (iPSCs) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Region in 2022
Figure 18. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players in 2022
Figure 24. Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Induced Pluripotent Stem Cells (iPSCs) Market Share in 2022
Figure 26. Global Top 6 Players Induced Pluripotent Stem Cells (iPSCs) Market Share in 2022
Figure 27. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Share by Type (2018-2023)
Figure 28. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2024-2029)
Figure 29. Global Induced Pluripotent Stem Cells (iPSCs) Consumption Value Share by Application (2018-2023)
Figure 30. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2024-2029)
Figure 31. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 41. France Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Region (2018-2029)
Figure 48. China Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 51. India Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Induced Pluripotent Stem Cells (iPSCs) Consumption Value (2018-2029) & (USD Million)
Figure 65. Induced Pluripotent Stem Cells (iPSCs) Market Drivers
Figure 66. Induced Pluripotent Stem Cells (iPSCs) Market Restraints
Figure 67. Induced Pluripotent Stem Cells (iPSCs) Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Induced Pluripotent Stem Cells (iPSCs) in 2022
Figure 70. Manufacturing Process Analysis of Induced Pluripotent Stem Cells (iPSCs)
Figure 71. Induced Pluripotent Stem Cells (iPSCs) Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
